Report cover image

Breast Cancer Therapeutics Market -Global Trends and Forecasts(2025 to 2034)

Publisher Factview Research
Published Nov 02, 2025
Length 198 Pages
SKU # FAVR20572996

Description

Breast Cancer Therapeutics Market Size And Forecast

According to Factview Research, Global Breast Cancer Therapeutics Market was valued at USD 18.54 Billion in 2024 and is projected to reach USD 44.58 Billion by 2034, growing at a CAGR of 10.2% from 2025 to 2034.

Global Breast Cancer Therapeutics Market Outlook

The Global breast cancer therapeutics market is driven by the rising prevalence of breast cancer pertaining to factors such as early menarche, prolonged exposure to endogenous oestrogens, late age at first childbirth and late menopause. Also, a rise in research and development funding for innovative drugs, high frequency of CSR activities carried out by corporates for awareness of breast cancer, mergers and acquisition are some other key factors propelling the market growth. Moreover, the growing adoption of therapeutics owing to factors such as blocking estrogenic from binding to tumor cells, risk of distant appearance, and reducing the risk of developing the disease in another breast are further expected to propel the growth of the market. On the other hand, increasing the cost of early and late-stage disease therapy, the prohibitive cost associated with the use of breast cancer therapeutics might hinder the growth of the market.

Global Breast Cancer Therapeutics Market Competitive Landscape

The Global Breast Cancer Therapeutics Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as AstraZeneca plc, Eisai Co. Ltd., Eli Lilly and Company, Roche Diagnostics, Novartis AG, Pfizer Inc., Celgene, Sanofi S.A., Teva Pharmaceutical and GlaxoSmithKline plc.

Table of Contents

198 Pages
1 Introduction Of Global Breast Cancer Therapeutics Market
1.1 Overview Of The Market
1.2 Scope Of Report
1.3 Assumptions
2 Executive Summary
3 Research Methodology Of Factview Research
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List Of Data Sources
4 Global Breast Cancer Therapeutics Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Breast Cancer Therapeutics Market, By Drug Class
5.1 Overview
5.2 Her2 Inhibitors
5.3 Mitotic Inhibitors
5.4 Anti-metabolites
5.5 Aromatase Inhibitors
5.6 Hormone Receptor Agonist/Antagonist
6 Global Breast Cancer Therapeutics Market, By Therapy
6.1 Overview
6.2 Chemotherapy
6.3 Radiation Therapy
6.4 Hormone Therapy
7 Global Breast Cancer Therapeutics Market, By Geography
7.1 Overview
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest Of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest Of Asia Pacific
7.5 Rest Of The World
7.5.1 Latin America
7.5.2 Middle East
8 Global Breast Cancer Therapeutics Market Competitive Landscape
8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies
9 Company Profiles
9.1 Astrazeneca Plc
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 Eisai Co. Ltd.
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Eli Lilly And Company
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Roche Diagnostics
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 Novartis Ag
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Pfizer Inc.
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 Celgene
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 Sanofi S.A.
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 Teva Pharmaceutical
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments
9.10 Glaxosmithkline Plc
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments
10 Appendix
10.1 Related Research

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us